Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$23.15 - $62.74
Next Earnings Date
May 14 2025
Next Earnings Date
May 14 2025
Latest price
Market Cap | $1.49B |
EV | $1.10B |
Shares Outstanding | 50.08M |
Beta | 0.76 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $62.75 |
P/E 2025E | - |
P/Revenue 2025E | 4.15x |
Revenue | 105.20% |
EPS | 37.60% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 12.40% |
EPS | -33.20% |
Operating Cash Flow | 23.10% |
Free Cash Flow | - |
Gross Margin 2025E | 97.75% |
Net Profit Margin 2025E | -22.46% |
ROE 2025E | -15.98% |
ROCE 2024 | -14.00% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Immunocore Holdings plc
IMCR
Sector
Healthcare
Industry
Biotechnology
CEO
Jallal, Bahija
Employees
493
Website
www.immunocore.comIPO Date
2021-02-05
Headquarters
92 Park Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RY, United Kingdom
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved